 |
Between the Biotech WavesAuthor: Nessan Bermingham PhD
Between the Biotech Wavesdiscussing recent developments and market dynamics impacting the biotech sector. Language: en-us Genres: Business, Investing, Life Sciences, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Episode 33: A Between the Biotech Waves conversation with Eliot Forster, xCEO of F-star Therapeutics
Episode 33
Tuesday, 18 July, 2023
Today I am talking to Eliot Forster xCEO of F-star Therapeutics.Eliot was at helm of the company as they reversed merged into Springbank Pharmaceuticals & through the recently announced acquisition by Sino Biopharma, a transaction that generated a lot of interest given the very public interactions with CFIUS.Prior to F-star, Eliot was CEO of Immunocore, Creabilis and Solace Pharmaceuticals following his multiple roles at Pfizer which included head of development and operations, European Union. He was the founding chair of Medcity and is an honorary visiting professor of molecular and clinical cancer medicine at the University of Liverpool, to name just a few roles he has had. Eliot is a member of the board of directors of Immatics and is chair of the boards of Ochre Biosciences and Avacta.
